Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone(GnRH)Antagonist Protocol in Women Undergoing IVF

NARecruitingINTERVENTIONAL
Enrollment

1,338

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Infertility
Interventions
DRUG

Generic cetrorelix acetate

Generic cetrorelix acetate (0.25 mg SC)

DRUG

Reference cetrorelix acetate

reference cetrorelix acetate (0.25 mg SC)

Trial Locations (1)

Unknown

RECRUITING

He Cai, Xi'an

All Listed Sponsors
lead

Northwest Women's and Children's Hospital, Xi'an, Shaanxi

OTHER